60 Degrees Pharmaceuticals, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 6 →Insiders1 insider bought $30,085 in 4 open-market buys. No sales.→HoldersKathmere 10.0%Citadel 0.8%XTX Topco 0.7%→Financing →PeersClosest companies: CRMD, FTH, OCUL→
From the filings
Figures
- Revenue
- $1.1Mlast 12 months
- Net income
- −$8.1Mlast 12 months
- Operating cash flow
- −$8.0Mlast 12 months
- Cash and equivalents
- $1.0Mat the last balance sheet
- Total debt
- $152,033at the last balance sheet
- Shares outstanding
- 2.7M shareson issue